{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:19:43Z","timestamp":1793344783142,"version":"4.5.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,28]]},"DOI":"10.1093\/cid\/ciy420","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T19:09:14Z","timestamp":1525979354000},"page":"1932-1947","source":"Crossref","is-referenced-by-count":41,"title":["Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"67","author":[{"given":"Annefleur C","family":"Langedijk","sequence":"first","affiliation":[{"name":"Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis A","family":"De Pijper","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Spijker","sequence":"additional","affiliation":[{"name":"Medical Library, Academic Medical Center, University of Amsterdam, The Netherlands"},{"name":"Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Holman","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Academic Medical Center, University of Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P","family":"Grobusch","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Stijnis","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"key\n\t\t\t\t2018112811052361200_CIT0001","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0002","first-page":"13","article-title":"Human rabies transmitted by dogs: current status of global data, 2015","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciu850","article-title":"Risk assessment for healthcare workers after a sentinel case of rabies and review of the literature","volume":"60","author":"Kan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0004","volume-title":"Rabies surveillance","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2165\/00003495-199856050-00005","article-title":"Current recommendations for the prophylaxis and treatment of rabies","volume":"56","author":"Dreesen","year":"1998","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0006","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper\u2014recommendations","volume":"28","author":"World Health Organization","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0007","volume-title":"WHO guide for rabies pre and post exposure prophylaxis in humans","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0008","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"Kessels","year":"2017","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0010","volume-title":"Rabies vaccines and immunoglobulins: WHO position. summary of 2017 updates. WHO\/CDS\/NTD\/NZD\/2018.04","author":"World Health Organization","year":"2018"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0011","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.1987.03390080049028","article-title":"Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination","volume":"257","author":"Bernard","year":"1987","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0012","first-page":"1","article-title":"Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57(RR-3)","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0013","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/j.vaccine.2016.09.058","article-title":"Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans","volume":"34","author":"Mansfield","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0014","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.trstmh.2009.03.007","article-title":"Immunogenicity and booster efficacy of pre-exposure rabies vaccination","volume":"103","author":"Strady","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0015","article-title":"All you wanted to know about rabies and more","volume-title":"Soci\u00e9t\u00e9 Belge d\u2019Infectiologie et de Microbiologie Clinique","author":"Soentjens","year":"2012"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0016","doi-asserted-by":"crossref","first-page":"403201","DOI":"10.4061\/2011\/403201","article-title":"Immunogenicity of simulated PCECV postexposure booster doses 1, 3, and 5 years after 2-dose and 3-dose primary rabies vaccination in schoolchildren","volume":"2011","author":"Kamoltham","year":"2011","journal-title":"Adv Prev Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0017","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cid\/cis853","article-title":"Rabies vaccinations: are abbreviated intradermal schedules the future","volume":"56","author":"Wieten","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0018","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0019","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0020","first-page":"1","article-title":"WHO expert committee on biological standardization. 56th report","author":"World Health Organization","year":"2007","journal-title":"World Health Organ Tech Rep Ser"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2105\/AJPH.74.5.503","article-title":"Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of immunized persons to intradermal booster vaccination","volume":"74","author":"Burridge","year":"1984","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2460\/javma.1987.191.02.185","article-title":"Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine","volume":"191","author":"Horman","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S0950268800066899","article-title":"Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose","volume":"99","author":"Rodrigues","year":"1987","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0035-9203(88)90539-1","article-title":"One year booster vaccination with purified Vero cell rabies vaccine","volume":"82","author":"Suntharasamai","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0026","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","article-title":"Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization","volume":"7","author":"Dreesen","year":"1989","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0027","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0264-410X(89)90159-X","article-title":"Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations","volume":"7","author":"Fishbein","year":"1989","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0028","first-page":"572","article-title":"Pre-exposure rabies immunization in occupational exposed milieu. A 5-year prospective and comparative study of immunogenicity","volume":"22","author":"Strady","year":"1993","journal-title":"Presse Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0029","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/515267","article-title":"Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy","volume":"177","author":"Strady","year":"1998","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0264-410X(96)00049-7","article-title":"Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults","volume":"14","author":"Briggs","year":"1996","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0031","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/513760","article-title":"Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations","volume":"25","author":"Kositprapa","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0032","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/biol.1998.0156","article-title":"Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)","volume":"26","author":"Lang","year":"1998","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0033","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00006454-199811000-00007","article-title":"Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine","volume":"17","author":"Sabchareon","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1086\/520143","article-title":"A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children","volume":"29","author":"Sabchareon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0035","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1086\/514737","article-title":"Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine","volume":"28","author":"Tantawichien","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0036","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0264-410X(00)00342-X","article-title":"Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons","volume":"19","author":"Briggs","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0037","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2310\/7060.2001.24445","article-title":"Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine","volume":"8","author":"Gherardin","year":"2001","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0038","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7060.2002.23189","article-title":"Four-site intradermal postexposure boosters in previously rabies vaccinated subjects","volume":"9","author":"Khawplod","year":"2002","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0039","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2310\/7060.2002.30088","article-title":"The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic","volume":"9","author":"Lau","year":"2002","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.3.5.4216","article-title":"Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination","volume":"3","author":"Morris","year":"2007","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0041","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies preexposure vaccination schedules","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0042","first-page":"393","article-title":"One or three intradermal injections within one week for rabies pre-exposure immunization","volume":"131","author":"Khawplod","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0043","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0044","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.vaccine.2008.04.033","article-title":"Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults","volume":"26","author":"Roukens","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0046","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0047","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.vaccine.2011.12.028","article-title":"One clinic visit for pre-exposure rabies vaccination (a preliminary one year study)","volume":"30","author":"Khawplod","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0048","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.vaccine.2013.02.058","article-title":"A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial","volume":"31","author":"Pichon","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0049","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.vaccine.2013.01.035","article-title":"Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis","volume":"31","author":"Wongsaroj","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1586\/14760584.2014.971764","article-title":"Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis","volume":"13","author":"Tantawichien","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0051","first-page":"269","article-title":"Effect of previous anti-rabies treatment with Fermi type vaccine on the antibody response to one dose of HDCV","volume":"64","author":"Vescia","year":"1985","journal-title":"Boll Ist Sieroter Milan"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0052","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","author":"Vodopija","year":"1997","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0053","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1708-8305.1999.tb00844.x","article-title":"Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously","volume":"6","author":"Naraporn","year":"1999","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0054","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0055","first-page":"157","article-title":"What are the consequences of having frequent rabies booster vaccinations","volume":"2","author":"Suwansrinon","year":"2008","journal-title":"Asian Biomed"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0056","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/CVI.05090-11","article-title":"Persistence of rabies antibody 5 years after postexposure prophylaxis with Vero cell antirabies vaccine and antibody response to a single booster dose","volume":"18","author":"Zhang","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0057","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2011.03.048","article-title":"Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV)","volume":"29","author":"Fayaz","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0058","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0091-6749(77)90078-1","article-title":"Induction of delayed hypersensitivity to protein antigens in mice without Freund adjuvants","volume":"60","author":"Crowle","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0059","first-page":"33","article-title":"Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine","volume":"5","author":"Phanuphak","year":"1987","journal-title":"Asian Pac J Allergy Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/14760584.2014.901893","article-title":"Intradermal vaccination for rabies prophylaxis: conceptualization, evolution, present status and future","volume":"13","author":"Madhusudana","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0061","first-page":"113","article-title":"Targeting skin dendritic cells to improve intradermal vaccination","volume":"351","author":"Romani","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0062","first-page":"7","article-title":"The intradermal vaccination: past experiences and current perspectives","volume":"51","author":"Sticchi","year":"2010","journal-title":"J Prev Med Hyg"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0063","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4269\/ajtmh.1985.34.633","article-title":"Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries","volume":"34","author":"Bernard","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0064","first-page":"77","article-title":"Delivery systems for intradermal vaccination","volume":"351","author":"Kim","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0066","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.1982.03320330034022","article-title":"Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses","volume":"247","author":"Bernard","year":"1982","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0067","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1708-8305.2008.00283.x","article-title":"Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention","volume":"16","author":"Altmann","year":"2009","journal-title":"J Travel Med"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0068","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13346-010-0005-z","article-title":"Enabling skin vaccination using new delivery technologies","volume":"1","author":"Kim","year":"2011","journal-title":"Drug Deliv Transl Res"},{"key":"key\n\t\t\t\t2018112811052361200_CIT0069","first-page":"729","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, October 2017\u2014conclusions and recommendations","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/12\/1932\/26826356\/ciy420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:39:17Z","timestamp":1751632757000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/12\/1932\/4996990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":69,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,5,17]]},"published-print":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy420","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,5,17]]}}}